372 related articles for article (PubMed ID: 17609270)
1. Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells.
Abdel-Motal UM; Guay HM; Wigglesworth K; Welsh RM; Galili U
J Virol; 2007 Sep; 81(17):9131-41. PubMed ID: 17609270
[TBL] [Abstract][Full Text] [Related]
2. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
3. Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.
Abdel-Motal U; Wang S; Lu S; Wigglesworth K; Galili U
J Virol; 2006 Jul; 80(14):6943-51. PubMed ID: 16809300
[TBL] [Abstract][Full Text] [Related]
4. Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes.
Galili U
Vaccine; 2020 Sep; 38(42):6487-6499. PubMed ID: 32907757
[TBL] [Abstract][Full Text] [Related]
5. Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.
Galili U
Med Res Arch; 2021 Jul; 9(7):. PubMed ID: 34853815
[TBL] [Abstract][Full Text] [Related]
6. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
[TBL] [Abstract][Full Text] [Related]
7. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
Deriy L; Ogawa H; Gao GP; Galili U
Cancer Gene Ther; 2005 Jun; 12(6):528-39. PubMed ID: 15818383
[TBL] [Abstract][Full Text] [Related]
8. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
Galili U
Immunol Cell Biol; 2005 Dec; 83(6):674-86. PubMed ID: 16266320
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of alpha-gal epitopes on influenza virus vaccines, by recombinant alpha 1,3galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody.
Henion TR; Gerhard W; Anaraki F; Galili U
Vaccine; 1997 Aug; 15(11):1174-82. PubMed ID: 9286041
[TBL] [Abstract][Full Text] [Related]
10. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.
Quan FS; Huang C; Compans RW; Kang SM
J Virol; 2007 Apr; 81(7):3514-24. PubMed ID: 17251294
[TBL] [Abstract][Full Text] [Related]
11. Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.
Yang S; Niu S; Guo Z; Yuan Y; Xue K; Liu S; Jin H
Virol J; 2013 Sep; 10():291. PubMed ID: 24053449
[TBL] [Abstract][Full Text] [Related]
12. Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopes.
Abdel-Motal UM; Wang S; Awad A; Lu S; Wigglesworth K; Galili U
Vaccine; 2010 Feb; 28(7):1758-65. PubMed ID: 20034607
[TBL] [Abstract][Full Text] [Related]
13. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral injection of alpha-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines.
Galili U; Wigglesworth K; Abdel-Motal UM
J Immunol; 2007 Apr; 178(7):4676-87. PubMed ID: 17372027
[TBL] [Abstract][Full Text] [Related]
15. Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.
Wang Z; Chua BY; Ramos JV; Parra SM; Fairmaid E; Brown LE; Jackson DC; Kedzierska K
Vaccine; 2015 Sep; 33(39):5148-54. PubMed ID: 26277069
[TBL] [Abstract][Full Text] [Related]
16. Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells.
Yan LM; Lau SPN; Poh CM; Chan VSF; Chan MCW; Peiris M; Poon LLM
mBio; 2020 Mar; 11(2):. PubMed ID: 32127444
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody.
Galili U; Repik PM; Anaraki F; Mozdzanowska K; Washko G; Gerhard W
Vaccine; 1996 Mar; 14(4):321-8. PubMed ID: 8744560
[TBL] [Abstract][Full Text] [Related]
18. [Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes].
Naĭkhin AN; Koren'kov DA; Chirkova TV; Petukhova GD; Donina SA; Rudenko LG
Vopr Virusol; 2011; 56(5):15-21. PubMed ID: 22171472
[TBL] [Abstract][Full Text] [Related]
19. Conversion of tumors into autologous vaccines by intratumoral injection of α-Gal glycolipids that induce anti-Gal/α-Gal epitope interaction.
Galili U
Clin Dev Immunol; 2011; 2011():134020. PubMed ID: 22162709
[TBL] [Abstract][Full Text] [Related]
20. Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
Galili U
Cancer Immunol Immunother; 2004 Nov; 53(11):935-45. PubMed ID: 15205919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
